This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB07938/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07938/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB07938/identifier/pubchem-substance/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07938/identifier/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07938
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB07938 n12:DB07938
dcterms:title
5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine
adms:identifier
n6:99444409 n7:I2H n8:44543639 n13:DB07938
n3:IUPAC-Name
n4:271B4E1F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4E25-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4E24-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4E21-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4E22-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4E23-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4E1D-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4E1E-363D-11E5-9242-09173F13E4C5 n4:271B4E1B-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4E1C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4E2B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4E2C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4E26-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4E27-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4E29-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4E28-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4E2A-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4E31-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4E33-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4E34-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4E30-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4E2F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4E32-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4E20-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4E2D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4E2E-363D-11E5-9242-09173F13E4C5